Holland named division of intramural research director for NIH

Steven M. Holland on Tuesday was named director of the division of intramural research (DIR) at the National Institutes of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

“Dr. Holland is widely respected within NIH and beyond as a highly skilled and dedicated physician-scientist and administrator,” NIAID Director Anthony Fauci said. “I am confident that with Steve’s leadership and scientific acumen, the NIAID intramural program will continue to build upon its strong tradition of discoveries that improve human health.”

Holland has been tasked with leading NIAID’s efforts to conduct basic and clinical research in areas related to immunology, allergy and infectious diseases.

Prior to his appointment, Holland served as the chief of NIAID’s Laboratory of Clinical Infectious Diseases since 2004 and as deputy director for NIH Intramural Clinical Research since 2011.

Holland’s areas of expertise include hyper-immunoglobin E syndrome, also known as Job’s syndrome, as well as genetic conditions that predispose certain individuals to acquiring mycobacterial infections. He recently studied genetic conditions that make certain people susceptible to severe coccidiomycosis, a fungal disease of the lungs and tissues.

Holland received his B.A. from St. John’s College and then earned his medical degree from Johns Hopkins University School of Medicine.